Lilly To Pay Conn. $25M Over Zyprexa Marketing
Eli Lilly & Co. is set to fork over $25.1 million to settle a lawsuit brought by the Connecticut Attorney General's Office for allegedly marketing its antipsychotic Zyprexa for unapproved uses...To view the full article, register now.
Already a subscriber? Click here to view full article